Braskem Sa (BAK) has released an update.
Braskem S.A., a leading producer in the Americas and global leader in biopolymers, has reported a 13% increase in Recurring EBITDA to US$211 million for the fourth quarter of 2023 compared to the previous quarter. Despite this growth, there was a year-over-year reduction in net revenue and sales volume of resins and main chemicals, reflecting the challenging market conditions. The company continues to navigate through various risks and uncertainties, which are detailed in its filings with the Brazilian Securities and Exchange Commission.
For further insights into BAK stock, check out TipRanks’ Stock Analysis page.
